Shopping Cart
- Remove All
- Your shopping cart is currently empty
DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM. DK419 decreases protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 and Survivin.It also induces production of pAMPK.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $79 | In Stock | |
5 mg | $173 | In Stock | |
10 mg | $273 | In Stock | |
25 mg | $451 | In Stock | |
50 mg | $636 | In Stock | |
100 mg | $858 | In Stock |
Description | DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM. DK419 decreases protein lelvels of Axin2, β-catenin, c-Myc, Cyclin D1 and Survivin.It also induces production of pAMPK. |
In vitro | DK419 inhibited the growth of CRC tumor cells in vitro and had good plasma exposure when dosed orally[1]. |
In vivo | DK419 inhibited the growth of patient derived CRC240 tumor explants in mice dosed orally[1]. |
Molecular Weight | 407.7 |
Formula | C16H8ClF6N3O |
Cas No. | 2102672-22-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: <1 mg/mL (insoluble or slightly soluble), Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.